Effect of Lorlatinib on brain metastasis
Lorlatinib is a tyrosine kinase inhibitor targeting non-small cell lung cancer (NSCLC). It has the effect of inhibiting ALK and ROS1 gene mutations. In clinical studies, lorlatinib has shown good efficacy in patients with brain metastases.
First of all, lorlatinib has strong blood-brain barrier penetration ability and can reach the drug concentration in the brain, thus exerting an inhibitory effect on brain metastases. Secondly, lorlatinib is highly selective for ALK and ROS1 gene mutations and can accurately target the growth and spread of cancer cells while having less impact on normal cells, thus reducing damage to surrounding tissues.

The results of multiple clinical studies have shown that lorlatinib has certain efficacy in the treatment of brain metastases. For patients with NSCLC and brain metastases carrying ALK or ROS1 gene mutations, lorlatinib is significantly more effective than other treatments and can significantly extend the patient's survival and improve their quality of life. In addition, the side effects of lorlatinib are relatively minor. Common side effects include headache, nausea and vomiting, and most patients can tolerate it.
In short, lorlatinib has good efficacy and low incidence of side effects in the treatment of brain metastases. Lorlatinib is a treatment option worth considering for patients with brain metastases from NSCLC harboring mutations in the ALK or ROS1 genes. However, specific treatment plans need to be formulated based on the patient's specific situation and the doctor's recommendations.
Lorlatinib has been launched in China and is included in medical insurance. Patients can purchase it domestically, but the price is relatively high, about 10,000 to 20,000 yuan. Please consult the local hospital pharmacy for details. There are original lorlatinib drugs and cheaper generic drugs abroad. The cheaper ones are the original drug from Turkey, which costs more than 1,000 yuan, and the original drug from Hong Kong, China, which costs about 30,000 yuan. Generic drugs are mainly generic drugs from Laos and Bangladesh. The price is about several thousand yuan, and the ingredients of the original drugs and generic drugs are basically the same.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)